ADMA Biologics CEO Adam Grossman's 2022 pay falls 39% to $2.6M
ADMA Biologics reports 2022 executive compensation
By ExecPay News
Published: April 13, 2023
ADMA Biologics reported fiscal year 2022 executive compensation information on April 13, 2023.
In 2022, two executives at ADMA Biologics received on average a compensation package of $2.1M, a 18% decrease compared to previous year.
Average pay of disclosed executives at ADMA Biologics
Adam S. Grossman, Chief Executive Officer, received $2.6M in total, which decreased by 39% compared to 2021. 32% of Grossman's compensation, or $837K, was in bonus. Grossman also received $629K in option awards, $637K in salary, $501K in stock awards, as well as $46K in other compensation.
Brian Lenz, Chief Financial Officer, received a compensation package of $1.6M, which decreased by 32% compared to previous year. 29% of the compensation package, or $472K, was in bonus.
Related executives
You may also like
Source: SEC filing on April 13, 2023.